Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy

被引：0
|
作者：
Alessandro Puzziello
Mario Carrano
Elisabetta Angrisani
Vincenzo Marotta
Antongiulio Faggiano
Pio Zeppa
Mario Vitale
机构：
[1] University of Salerno,Department of Medicine and Surgery
[2] AOU San Giovanni di Dio e Ruggi d’Aragona,S.C. Endocrinologia
[3] University “Federico II”,Department of Clinical Medicine and Surgery
来源：
Journal of Endocrinological Investigation | 2014年 / 37卷
关键词：
Thyroid; Benign nodular goiter; Levothyroxine; Ultrasonography;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1181 / 1186
页数：5
相关论文
共 50 条
  • [41] Risk-benefit ratio for TSH- suppressive Levothyroxine therapy in differentiated thyroid cancer
    Do Cao, C.
    Wemeau, J. -L.
    ANNALES D ENDOCRINOLOGIE, 2015, 76 : 1S47 - 1S52
  • [42] Effect of Suppressive Levothyroxine Therapy on Bone Mineral Density in Young Patients with Differentiated Thyroid Carcinoma
    Zanella, Andre Borsatto
    Marmitt, Laura
    Fighera, Tayane Muniz
    Scheffel, Rafael Selbach
    Spritzer, Poli Mara
    Dora, Jose Miguel
    Maia, Ana Luiza
    METABOLITES, 2022, 12 (09)
  • [43] SUPPRESSIVE THERAPY OF THYROID-NODULES IN PATIENTS WITH PREVIOUS RADIOTHERAPY TO THE HEAD AND NECK
    RAZACK, MS
    SHIMAOKA, K
    SAKO, K
    RAO, U
    AMERICAN JOURNAL OF SURGERY, 1988, 156 (04): : 290 - 293
  • [44] Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy
    Vera, Lara
    Gay, Stefano
    Campomenosi, Claudia
    Paolino, Sabrina
    Pera, Giorgia
    Monti, Eleonora
    Mortara, Lorenzo
    Seriolo, Bruno
    Giusti, Massimo
    ENDOKRYNOLOGIA POLSKA, 2016, 67 (04) : 350 - 358
  • [45] Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer
    Marotta, Vincenzo
    Bifulco, Maurizio
    Vitale, Mario
    CANCERS, 2021, 13 (15)
  • [46] In Reply-Radiofrequency Ablation Therapy for Large Benign Thyroid Nodules
    Hamidi, Oksana
    Callstrom, Matthew R.
    Lee, Robert A.
    Dean, Diana
    Castro, M. Regina
    Morris, John C., III
    Stan, Marius N.
    MAYO CLINIC PROCEEDINGS, 2018, 93 (09) : 1328 - 1329
  • [47] The majority of Danish non-toxic goitre patients are ineligible for Levothyroxine suppressive therapy
    Fast, S.
    Bonnerna, S. J.
    Hegedus, L.
    HORMONE RESEARCH, 2007, 68 : 74 - 74
  • [48] Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy
    Verburg, Frederik A.
    Smit, Johannes W. A.
    Grelle, Inge
    Visser, Theo J.
    Peeters, Robin P.
    Reiners, Christoph
    CLINICAL ENDOCRINOLOGY, 2012, 76 (04) : 577 - 581
  • [49] Cognitive dysfunctions during chronic Thyrotropin-suppressive therapy with levothyroxine in patients with differentiated thyroid carcinoma
    Jaracz, J.
    Kucharska, A.
    Rajewska-Rager, A.
    Lacka, K.
    EUROPEAN PSYCHIATRY, 2008, 23 : S379 - S379
  • [50] Factors associated with HIV RNA levels in pregnant women on non-suppressive highly active antiretroviral therapy at conception
    Patel, Deven
    Cortina-Borja, Mario
    De Maria, Andrea
    Newell, Marie-Louise
    Thorne, Claire
    ANTIVIRAL THERAPY, 2010, 15 (01) : 41 - 49
12345